Sources
[1] Greenland P, et al. (2018). Coronary Calcium Score and Cardiovascular Risk. Journal of the American College of Cardiology, 72(4), 434-447. Link
[2] Kanaya AM, et al. (2014). Comparing coronary artery calcium among U.S. South Asians with four racial/ethnic groups. Atherosclerosis, 234(1), 102-107. PubMed
[3] Hecht HS, et al. (2017). Clinical indications for coronary artery calcium scoring in asymptomatic patients. Journal of Cardiovascular Computed Tomography, 11(2), 157-168. Link
[4] Budoff MJ, et al. (2018). Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease events. JAMA Cardiology, 3(4), 281-289. PubMed
[5] Arnett DK, et al. (2019). ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease. Circulation, 140, e596-e646. Link
[6] Newby DE, et al. (2018). Coronary CT Angiography and 5-Year Risk of Myocardial Infarction. New England Journal of Medicine, 379, 924-933. NEJM
[7] Sniderman AD, et al. (2019). Apolipoprotein B Particles and Cardiovascular Disease. JAMA Cardiology, 4(12), 1287-1295. PubMed
[8] Grundy SM, et al. (2019). AHA/ACC/Multisociety Cholesterol Guideline. Journal of the American College of Cardiology, 73(24), e285-e350. Link
[9] Collins R, et al. (2016). Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet 388(10059), 2532-2561. PubMed
[10] Reynolds A, et al. (2019). Carbohydrate quality and human health. Lancet, 393(10170), 434-445. PubMed
[11] Ras RT, et al. (2014). LDL-cholesterol-lowering effect of plant sterols and stanols. British Journal of Nutrition, 112(2), 214-219. PubMed
[12] Jenkins DJ, et al. (2011). Effect of a dietary portfolio on LDL cholesterol. JAMA, 306(8), 831-839. PubMed
[13] Pelliccia A, et al. (2021). ESC Guidelines on sports cardiology and exercise. European Heart Journal, 42(1), 17-96. Link
[14] Schwalfenberg GK. (2017). Vitamins K1 and K2: The Emerging Group of Vitamins. Journal of Nutrition and Metabolism, 2017, 6254836. PubMed
[15] DiNicolantonio JJ, et al. (2018). Magnesium for the prevention and treatment of cardiovascular disease. Open Heart, 5(2), e000775. PubMed
[16] Bhatt DL, et al. (2019). Cardiovascular Risk Reduction with Icosapent Ethyl. New England Journal of Medicine, 380, 11-22. NEJM
[17] Cappuccio FP, et al. (2011). Sleep duration predicts cardiovascular outcomes. European Heart Journal, 32(12), 1484-1492. PubMed
[18] Levine GN, et al. (2017). Meditation and Cardiovascular Risk Reduction. Journal of the American Heart Association, 6(10), e002218. Link
[19] Sanz M, et al. (2020). Periodontitis and cardiovascular diseases. Nature Reviews Cardiology, 17, 487-502. PubMed
[20] Peng AW, et al. (2020). Very High Coronary Artery Calcium and Outcomes. JACC: Cardiovascular Imaging, 13(5), 1160-1171. Link